Diario digital con noticias de actualidad relacionadas con el mundo de la salud. Novedades, encuestas, estudios, informes, entrevistas. Con un sencillo lenguaje dirigido a todo el mundo. Y algunos consejos turísticos para pasarlo bien
Traductor
07 April 2011
Novartis sells Meda rights to atopic dermatitis drug Elidel for $420 million
Novartis said Thursday that it agreed to sell global rights to manufacture, market and commercialise the atopic dermatitis treatment Elidel (pimecrolimus) to Meda for an upfront payment of $420 million. The Swiss drugmaker noted that the deal "reflects [its] strategy to focus commercialisation on new launch portfolio and core brands." Upon closing of the transaction, which is expected in the second quarter of the year, Meda will assume the global manufacturing of Elidel within three years. **Published in "First Word"
Subscribe to:
Post Comments (Atom)
CONTACTO · Aviso Legal · Política de Privacidad · Política de Cookies
Copyright © Noticia de Salud
No comments:
Post a Comment